20672 ⎘
Medicinal preparations containing materials or reaction products thereof with undetermined constitution; Microorganisms or materials therefrom; Viruses; Subviral particles; Bacteriophages Adenovirus
VIRAL EXPRESSION CONSTRUCT COMPRISING A FIBROBLAST GROWTH FACTOR (FGF21) CODING SEQUENCE
#2MINIGENE THERAPY
#3REELIN COMPOSITIONS FOR TREATMENT OF NEUROLOGICAL DISORDERS
#4REGULATION OF RAN TRANSLATION BY PKR AND EIF2A-P PATHWAYS
#5ONCOLYTIC ADENOVIRAL VECTOR AND METHODS OF USE
#6ADENOVIRUS FORMULATIONS
#7Enhanced adoptive cell therapy
#8COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATMENT OF METABOLIC DISEASES AND RELATED DISORDERS
#9A REPLICATIVE ONCOLYTIC ADENOVIROUS CAPABLE OF INHIBITING TUMOR PROGRESSION AND PROLONGING SURVIVAL TIME IN TUMOR-BEARING INDIVIDUALS AND USE THEREOF
#10ADENO-ASSOCIATED VIRUS VECTOR DELIVERY OF MICRO-DYSTROPHIN TO TREAT MUSCULAR DYSTROPHY
#11METHODS OF TREATING BLADDER CANCER
#12MEANS AND METHODS FOR AAV GENE THERAPY IN HUMANS
#13TUMOR SELECTIVE TATA-BOX AND CAAT-BOX MUTANTS
#14METHOD FOR THE PURIFICATION OF RECOMBINANT ADENOVIRUS VECTORS
#15AAV-Mediated Gene Transfer for Retinopathy
#16CNS DELIVERY OF THERAPEUTIC AGENTS
#17ADENO-ASSOCIATED VIRUS VIRION FOR TREATING ORNITHINE TRANSCARBAMYLASE DEFICIENCY
#18RECOMBINANT ADENOVIRUSES AND USES THEREOF
#19ONCOLYTIC VIRUS THERAPY
#20TUMOR-SELECTIVE E1A AND E1B MUTANTS
#21Methods for Delivery of Polynucleotides by Adeno-Associated Virus for Lysosomal Storage Disorders
#22METHODS OF TREATING SOLID OR LYMPHATIC TUMORS BY COMBINATION THERAPY
#23REPROGRAMMED FUNCTIONAL FRAGMENT OF RECOMBINANT ONCOLYTIC VIRUS, COMBINATION, AND APPLICATION THEREOF
#24VARIANT RNAi
#25MUTANT E1A ANTAGONIZING UBIQUITINATION-MEDIATED DEGRADATION AND ITS USE IN THE PREPARATION OF POTENTIATED ONCOLYTIC ADENOVIRUSES AND IMMUNE POTENTIATORS
#26VIRAL DELIVERY OF NEOANTIGENS
#27TREATMENT OF HEART DISEASE BY DISRUPTION OF THE ANCHORING OF PP2A
#28ADENOVIRUS CONSTRUCTS AND METHODS OF USE
#29An LTBR Agonist In Combination Therapy Against Cancer
#30Recombinant Viral Genomes and Related Compositions and Methods
#31THERAPEUTIC AGENT FOR NEURODEGENERATIVE DISEASE
#32ADENOVIRUS EXPRESSING IMMUNE CELL STIMULATORY RECEPTOR AGONIST(S)
#33ADENO-ASSOCIATED VIRUS VECTOR DELIVERY OF MICRO-DYSTROPHIN TO TREAT MUSCULAR DYSTROPHY
#34METHODS AND COMPOSITIONS FOR CNS DELIVERY OF ARYLSULFATASE A
#35VIRAL GENE THERAPY AS TREATMENT FOR CHOLESTEROL STORAGE DISEASE OR DISORDER
#36NASAL ANTI-CANCER THERAPIES
#37A GENE THERAPY STRATEGY TO RESTORE ELECTRICAL AND CARDIAC FUNCTION, AND CARDIAC STRUCTURE, IN ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY
#38METHODS AND COMPOSITIONS FOR CNS DELIVERY OF IDURONATE-2-SULFATASE
#39COMPOSITION AND METHODS FOR MODULATION OF ELOVL2
#40ANTICANCER COMPOSITION COMPRISING RECOMBINANT ADENOVIRUS EXPRESSING DEGRADATION FACTOR FOR EXTRACELLULAR MATRIX
#41RECOMBINANT AAV FOR THE GENE THERAPY OF FABRY DISEASE
#42GENE THERAPY FOR CILIOPATHIES
#43ADENOVIRUSES AND METHODS FOR USING ADENOVIRUSES
#44ADENOVIRUS ARMED WITH BISPECIFIC T CELL ACTIVATOR
#45ONCOLYTIC ADENOVIRUSES FOR TREATING CANCER
#46AAV-MEDIATED GENE TRANSFER FOR RETINOPATHY
#47GROUP B ADENOVIRUS-CONTAINING FORMULATION
#48SELECTIVE CELL TARGETING USING ADENOVIRUS AND CHEMICAL DIMERS
#49COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY DISEASE
#50ONCOLYTIC ADENOVIRUSES ARMED WITH HETEROLOGOUS GENES
#51MEMBRANE LIPID COATED NANOPARTICLES AND METHOD OF USE
#52Adenoviral Vector
#53SELECTIVE STIMULATION OF T CELLS IN SOLID TUMORS USING ONCOLYTIC VIRAL DELIVERY OF ORTHOGONAL IL-2
#54COMPOSITIONS AND METHODS FOR ACHIEVING HIGH LEVELS OF TRANSDUCTION IN HUMAN LIVER CELLS
#55IMMUNOEVASIVE ANTI-TUMOR ADENOVIRUS
#563-SUBSTITUTED PIPERIDINE COMPOUNDS FOR CBL-B INHIBITION, AND USE THEREOF
#57Recombinant adenoviruses and uses thereof
#58ADENOVIRUS FOR ANTI-TUMOUR THERAPY
#59METHODS OF HEAT INACTIVATION OF ADENOVIRUS
#60Therapeutic pharmaceutical composition for bone and soft tissue tumors
#61GROUP B ADENOVIRUS ENCODING AN ANTI-TCR-COMPLEX ANTIBODY OR FRAGMENT
#62AAV CAPSIDS WITH INCREASED TROPISM TO BRAIN TISSUE
#63ADENOVIRUS FOR TREATMENT OF CANCER
#64VIRAL EXPRESSION CONSTRUCT COMPRISING A FIBROBLAST GROWTH FACTOR 21 (FGF21) CODING SEQUENCE
#65ADENOVIRUS ENCODING IL-15
#66MODIFIED ADENOVIRUS
#67Compositions and Methods for Producing Recombinant AAV
#68TREATMENT OF HEART DISEASE BY DISRUPTION OF THE ANCHORING OF PP2A
#69OPTOGENETIC VISUAL RESTORATION USING CHRIMSON
#70CHIMERIC BROAD-SPECTRUM ONCOLYTIC ADENOVIRUS WITH MULTIPLE MECHANISMS SYNERGIZING WITH AND ENHANCING EFFICACY OF IMMUNOTHERAPY, AND APPLICATION THEREOF IN TUMOR TREATMENT
#71MUC16 PROMOTER CONTAINING VIRUS
#72Oncolytic Virus and Methods of Use
#73ONCOLYTIC VIRUS (ONCOLYTIC IMMUNOTHERAPY) CAPABLE OF EFFECTIVELY TREATING EVEN METASTATIC CANCER WHILE ENSURING SAFETY, WITH EXPRESSION CONTROL SYSTEM PROVIDING OPTIMAL EXPRESSION LEVEL OF MOUNTED IMMUNOGENIC GENE
#74COMPOSITIONS AND METHODS FOR TREATING CEP290 ASSOCIATED DISEASE
#75PROSTATE NEOANTIGENS AND THEIR USES
#76GENE THERAPIES FOR LYSOSOMAL DISORDERS
#77NOVEL ADENO-ASSOCIATED VIRUS (AAV) CLADE F VECTOR AND USES THEREFOR
#78ADENO-ASSOCIATED VIRUS VECTOR PHARMACEUTICAL COMPOSITION AND METHODS
#79ISOLATED RECOMBINANT ONCOLYTIC ADENOVIRUSES, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF FOR DRUGS FOR TREATMENT OF TUMORS AND/OR CANCERS
#80Compositions and methods of treating ocular diseases
#81METHODS AND MATERIALS FOR TREATING CANCER
#82MINIGENE THERAPY
#83Compositions and Methods for Treating Retinal Disorders
#84VIRAL DELIVERY OF NEOANTIGENS
#85Adenoviruses and methods for using adenoviruses
#86IMMUNOTHERAPEUTIC VACCINE AND ANTIBODY COMBINATION THERAPY
#87COMPOSITIONS AND METHODS FOR TREATING MOTOR NEURON DISEASES
#88PREVENTION AND/OR TREATMENT OF HEARING LOSS OR IMPAIRMENT
#89MODIFIED HTERT PROMOTER FOR REGULATING CANCER CELL-SPECIFIC GENE EXPRESSION AND ANTI-TUMOR ADENOVIRUS CONTAINING SAME
#90VARIANT RNAi
#91AAV CAPSID DESIGNS
#92REPLICATIVE ONCOLYTIC ADENOVIRUS FOR REGULATING LIPID METABOLISM AND USE THEREOF
#93Adenoviruses and methods for using adenoviruses
#94ADENO-ASSOCIATED VIRUS FOR DELIVERY OF KH902 (CONBERCEPT) AND USES THEREOF
#95AAV-Mediated Gene Transfer for Retinopathy
#96ADENOVIRUS COMPRISING AN ALBUMIN-BINDING MOIETY
#97Compositions and Methods of Treatment
#98Combination Treatment Method with E10A and PD1 Monoclonal Antibody for Tumor and Pharmaceutical Application
#99Compositions and methods for treating inflammatory disease
#100CELLULAR COMPOSITIONS AND METHODS OF TREATMENT
#101GENE THERAPIES FOR LYSOSOMAL DISORDERS
#102ONCOLYTIC VIRUSES AS ADJUVANTS
#103POTENT AND BALANCED BIDIRECTIONAL PROMOTER
#104PHARMACEUTICAL COMPOSITION OF ENZYMES AND VIRUSES AND APPLICATION THEREOF
#105Tumor-selective E1a and E1b mutants
#106CELLULAR REPROGRAMMING OF HUMAN ADIPOCYTES
#107RECOMBINANT ADENOVIRUS GENOME HAVING A SYNTHETIC TRANSCRIPTIONAL UNIT AND TWO STEP TRANSCRIPTIONAL REGULATION AND AMPLIFICATION
#108RAPID VACCINE PLATFORM
#109ONCOLYTIC ADENOVIRUS WITH REPLICATION SELECTIVITY BASED ON STATUS OF P53 TRANSCRIPTIONAL ACTIVITY
#110MESENCHYMAL STEM CELLS THAT ENABLE TUMOR TARGETING IMPROVEMENT AND VIRUS MASS-PRODUCTION
#111REDIRECTION OF TROPISM OF AAV CAPSIDS
#112Butyrylcholinesterases having an enhanced ability to hydrolyze acyl ghrelin
#113ADENO-ASSOCIATED VIRUS VECTOR DELIVERY OF MICRO-DYSTROPHIN TO TREAT MUSCULAR DYSTROPHY
#114CNS DELIVERY OF THERAPEUTIC AGENTS
#115USE OF CD83 IN COMBINATION THERAPIES
#116DELIVERY OF SIALIDASE TO CANCER CELLS, IMMUNE CELLS AND THE TUMOR MICROENVIRONMENT
#117ENGINEERED ONCOLYTIC ADENOVIRUS
#118NEURAL STEM CELL-MEDIATED CANCER TREATMENT
#119STRUCTURE OF ONCOLYTIC VIRUS COMPRISING BISPECIFIC NUCLEIC ACID MOLECULE
#120COMBINATION ANTI-CANCER THERAPIES WITH INDUCERS OF IRON-DEPENDENT CELLULAR DISASSEMBLY
#121Nanoparticle Modification of Human Adipose-Derived Mesenchymal Stem Cells for Treating Brain Cancer and Other Neurological Diseases
#122Fractal Combination Therapy
#123METHODS AND COMPOSITIONS FOR DELIVERY OF AGENTS ACROSS THE BLOOD-BRAIN BARRIER
#124GENE THERAPY FOR TREATING CDKL5 DEFICIENCY DISORDER
#125Methods of treating solid or lymphatic tumors by combination therapy
#126Methods and compositions for CNS delivery of iduronate-2-sulfatase
#127REGULATION OF RAN TRANSLATION BY PKR AND EIF2A-P PATHWAYS
#128Adeno-Associated Virus Vector Delivery of Microrna-29 to Treat Muscular Dystrophy
#129DETARGETED ADENOVIRUS VARIANTS AND RELATED METHODS
#130Means and methods for AAV gene therapy in humans
#1313-substituted piperidine compounds for Cbl-b inhibition, and use thereof
#132VIRUSES WITH MODIFIED CAPSID PROTEINS
#133TREATMENT OF TUMORS BY A COMBINATION OF AN ONCOLYTIC ADENOVIRUS, A CDK4/6 INHIBITOR AND A FURTHER THERAPEUTICALLY ACTIVE AGENT
#134PROCESS OF MAKING MEMBRANE LIPID COATED NANOPARTICLES
#135COCHLEAR INNER HAIR CELL PROMOTERS AND USES THEREOF
#136ANTICANCER COMPOSITION COMPRISING TUMOR-SPECIFIC ONCOLYTIC ADENOVIRUS AND IMMUNE CHECKPOINT INHIBITOR
#137MEMBRANE LIPID COATED NANOPARTICLES AND METHOD OF USE
#138THERAPEUTIC AGENTS COMPRISING ONCOLYTIC VACCINIA VIRUSES AND NK CELLS, AND USES THEREOF FOR DRUGS FOR TREATMENT OF TUMORS AND/OR CANCERS
#139METHOD FOR REVERSING MULTIPLE RESISTANCE IN ANIMAL CELLS
#140Methods of treating bladder cancer
#141TREATMENT METHODS USING ADENOVIRUS
#142ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR RESTORING PAH GENE FUNCTION AND METHODS OF USE THEREOF
#143COMPOSITIONS OF EXOSOMES AND AAV
#144GENE THERAPY FOR TREATING PHENYLKETONURIA
#145TARGETED CANCER THERAPY
#146METHODS OF TREATING BLADDER CANCER
#147COMPOSITIONS FOR TREATMENT OF WET AGE-RELATED MACULAR DEGENERATION
#148Membrane lipid coated nanoparticles and method of use
#149Adeno-associated virus virions for treatment of epilepsy
#150TREATMENT OF AMD USING AAV2 VARIANT WITH AFLIBERCEPT
#151Compositions and methods for enhanced gene expression in cone cells
#152POLYMER NANOPARTICLE COMPOSITION FOR DELIVERING VIRUS, AND PREPARATION METHOD THEREFOR
#153Recombinantly-modified adeno-associated virus (rAAV) having improved packaging efficiency
#154GENE THERAPY FOR MESOTHELIOMA
#155METHOD FOR ADMINISTERING ONCOLYTIC VIRUS TO TUMOR TISSUE, AND DEVICE FOR ADMINISTRATION
#156Composition for treatment of Crigler-Najjar syndrome
#157METHODS AND COMPOSITIONS COMPRISING ENHANCED TARGETED IMMUNE GENE THERAPY FOR THE TREATMENT OF CANCER
#158Adenoviral vector
#159VIRUS AND TUMOR THERAPEUTIC DRUG FOR SPECIFICALLY KILLING TUMOR CELLS
#160MODIFIED INTERLEUKIN 12 AND USE THEREOF IN PREPARING DRUGS FOR TREATING TUMOURS
#161Replication Deficient Adenoviral Vectors for HIV Vaccine Applications
#162GMCI AND DDRI COMBINATION THERAPY FOR TREATING CANCER
#163Compositions And Methods For Viral Delivery Of Neoepitopes And Uses Thereof
#164Replicative oncolytic adenovirus for regulating lipid metabolism and use thereof
#165METHODS AND COMPOSITIONS FOR TRANSGENE EXPRESSION
#166METHODS OF PRODUCING ADENOVIRUS
#167METHODS FOR TREATING INHERITED EYE DEFECTS
#168METHODS AND COMPOSITIONS FOR TREATING CONDITIONS USING RECOMBINANT SELF-COMPLEMENTARY ADENO-ASSOCIATED VIRUS
#169METHODS FOR INDUCING AN IMMUNE RESPONSE AGAINST NEOANTIGENS
#170ONCOLYTIC ADENOVIRAL VECTOR EXPRESSING PEPTIDYLARGININE DEIMINASE AND TISSUE INHIBITOR OF METALLOPROTEINASE
#171PV-DELETED BOVINE ADENOVIRUS
#172SEQUENTIAL HETEROLOGOUS BOOST ONCOLYTIC VIRAL IMMUNOTHERAPY
#173ONCOLYTIC ADENOVIRAL VECTOR EXPRESSING A MEMBER OF THE B7 FAMILY OF COSTIMULATORY LIGANDS AND ADA
#174MODIFIED ADENOVIRUS AND MEDICINE COMPRISING SAME
#175ONCOLYTIC VIRUSES AND METHODS FOR USING ONCOLYTIC VIRUSES
#176DYNAMIC COVALENTLY LINKED HYDROGELS AS STABILIZATION NETWORK PLATFORMS
#177TREATMENT OF SANFILIPPO SYNDROME TYPE B
#178Methods and compositions for CNS delivery of heparan N-sulfatase
#179Recombinant adenoviruses carrying transgenes
#180ALPHAVIRUS NEOANTIGEN VECTORS AND INTERFERON INHIBITORS
#181METHODS AND COMPOSITIONS FOR INDUCING PROTECTIVE IMMUNITY AGAINST RSV INFECTION
#182METHODS OF TREATING SOLID OR LYMPHATIC TUMORS BY COMBINATION THERAPY
#183COMPOSITIONS AND METHODS FOR TREATING CANCER
#184COMPOSITION AND METHODS FOR MODULATION OF ELOVL2
#185Trans-splicing ribozyme targeting rhodopsin transcript and uses thereof
#186TREATMENT OF OCULAR NEOVASCULARIZATION USING ANTI-VEGF PROTEINS
#187NEUROD1 VECTOR
#188VECTORIZED ANTIBODIES AND USES THEREOF
#189ONCOLYTIC ADENOVIRUS COMPOSITIONS
#190PH-sensitive and bioreducible polymer-virus complex for cancer treatment
#191Methods and compositions for delivery of agents across the blood-brain barrier
#192Methods of heat inactivation of adenovirus
#193METHOD AND COMPOSITION AGAINST VIRUS INFECTIONS WITH ACTIVATED INNATE LYMPHOID CELLS (ILCS)
#194Enhancing AAV-mediated transduction of ocular tissues with hyaluronic acid
#195ADENOSOMES
#196DOSING REGIME AND FORMULATIONS FOR TYPE B ADENOVIRUSES
#197AAV-mediated BMI1 gene transfer for treating macular degeneration
#198AAV capsids with increased tropism to brain tissue
#199MODULATION OF SPTLC1 VIA RECOMBINANT ADENO-ASSOCIATED VECTORS
#200Method of reducing neuronal microtubule binding protein Tau (Tau) levels
#201Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
#202COMPOSITION COMPRISING NC886 FOR IMPROVING ONCOLYTIC VIRUS ACTIVITY OR PRODUCTION
#203ADENO-ASSOCIATED VIRUS VARIANTS AND METHODS OF USE THEREOF
#204TREATMENT OF HEART DISEASE BY DISRUPTION OF THE ANCHORING OF PP2A
#205COMPOSITIONS AND METHODS
#206Therapeutic agent for neurodegenerative disease
#207A METHOD FOR TREATING AN AUDITORY NEUROPATHY SPECTRUM DISORDER
#208PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CARTILAGE DISEASES
#209IMMUNOMODULATORY ONCOLYTIC ADENOVIRAL VECTORS, AND METHODS OF PRODUCTION AND USE THEREOF FOR TREATMENT OF CANCER
#210Modulation of AAV Vector Transgene Expression
#211COMPOSITIONS AND METHODS USEFUL FOR TARGETING THE BLOOD-BRAIN BARRIER
#212NOVEL METHODS FOR INDUCING AN IMMUNE RESPONSE
#213ANTI-TUMOR COMPOSITION
#214METHODS OF TREATING TIM-3 ELEVATION
#215ADENOVIRUSES AND METHODS FOR USING ADENOVIRUSES
#216Method and composition for treating neuropathic pain
#217ADENO-ASSOCIATED VIRUS (AAV) SEROTYPE 8 SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREFOR
#218ONCOLYTIC ADENOVIRUS ENCODING A B7 PROTEIN
#219Adeno-associated virus purification methods
#220Methods and Compositions for Treating Neurodegeneration and Fibrosis
#221COMPOSITIONS OF STING VARIANTS, COMBINATIONS THEREOF, AND METHODS FOR INDUCING AND ENHANCING AN IMMUNE RESPONSE AGAINST INFECTIONS, DISEASES, AND DISORDERS
#222ADENOVIRUS EXPRESSING IMMUNE CELL STIMULATORY RECEPTOR AGONIST(S)
#223NOVEL THERAPY TO ACHIEVE GLYCEMIC CONTROL
#224METHODS AND COMPOSITIONS FOR DELIVERY OF AGENTS ACROSS THE BLOOD-BRAIN BARRIER
#225TREATMENT OF MUCOPOLYSACCHARIDOSIS I WITH FULLY-HUMAN GLYCOSYLATED HUMAN ALPHA-L-IDURONIDASE (IDUA)
#226PHARMACOLOGIC TREATMENT FOR RIGHT VENTRICULAR FAILURE
#227AAV TRIPLE-PLASMID SYSTEM
#228Oncolytic virus or antigen presenting cell mediated cancer therapy using type I interferon and CD40-ligand
#229MATERIALS AND METHODS FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS AND/OR FRONTAL TEMPORAL LOBULAR DEGENERATION
#230TREATMENT OF BRAIN CANCER WITH ONCOLYTIC ADENOVIRUS
#231Membrane lipid coated nanoparticles and method of use
#232Recombinant replication competent viruses comprising a coding region for glycogen synthase kinase-3 (GSK3) and methods of killing aberrant cells
#233METHODS AND COMPOSITIONS FOR USING METAL ELEMENTS IN AAV GENE THERAPY
#234ONCOLYTIC RHABDOVIRUS
#235Oncolytic adenoviruses armed with heterologous genes
#236Tumor-selective E1A and E1B mutants
#237METHODS AND COMPOSITIONS FOR THE TREATMENT OF HEPATIC AND METABOLIC DISEASES
#238Adeno-associated virus compositions for restoring PAH gene function and methods of use thereof
#239Replication-enhanced oncolytic adenoviruses
#240AAV TRANSFER CASSETTE
#241Combining adenovirus and checkpoint inhibitors for treating cancer
#242Group B adenovirus-containing formulation
#243Viral gene therapy as treatment for cholesterol storage disease or disorder
#244Combination comprising HDAC inhibitor and CD137 agonist for cancer therapy
#245Mosaic chimeric viral vaccine particle
#246METHODS OF TREATING OCULAR NEOVASCULAR DISEASES USING AAV2 VARIANTS ENCODING AFLIBERCEPT
#247Modified adenoviruses
#248Use of MIR101 or MIR128 in the treatment of seizure disorders
#249Methods of treating bladder cancer with an oncolytic virus
#250COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATMENT OF METABOLIC DESEASES AND RELATED DISORDERS
#251COMPOSITIONS FOR DRG-SPECIFIC REDUCTION OF TRANSGENE EXPRESSION
#252NOVEL ADENOVIRUS
#253CRISPR and LASER ART Eliminates HIV
#254TROPIC CELL BASED VIROTHERAPY FOR THE TREATMENT OF CANCER
#255REAGENT COATED LENSES
#256NANOPARTICULATE MINERALIZED COLLAGEN GLYCOSAMINOGLYCAN SCAFFOLD WITH AN ANTI-RESORPTION FACTOR
#257MICROCIN THAT AMPLIFIES SHIGA TOXIN PRODUCTION OF FOODBORNE PATHOGEN E. COLI
#258TREATMENT OF TUMORS BY A COMBINATION OF AN ONCOLYTIC ADENOVIRUS AND A CDK4/6 INHIBITOR
#259ENHANCED VIRAL DELIVERY FORMULATION
#260TREATMENT OF MYOTONIC DYSTROPHY
#261ONCOLYTIC ADENOVIRUS COMPOSITIONS WITH ENHANCED REPLICATION PROPERTIES
#262MODIFIED ONCOLYTIC ADENOVIRUSES
#263Personalized cancer vaccines
#264Oncolytic virus (oncolytic immunotherapy) capable of effectively treating even metastatic cancer while ensuring safety, with expression control system providing optimal expression level of mounted immunogenic gene
#265Methods and compositions for CNS delivery of arylsulfatase A
#266Enhancing AAV-mediated transduction of ocular tissues with hyaluronic acid
#267Adeno-associated virus vector
#268Enhanced adoptive cell therapy
#269Recombinant adenoviruses and uses thereof
#270Lipin-1 as a novel therapy target of muscular dystrophy
#271Composite biological agent based on porous frame materials
#272ONCOLYTIC VIRUSES AS ADJUVANTS
#273Compositions and methods for treating retinal disorders
#274Recombinant human replication-deficient adenovirus comprising a modified nucleic acid encoding the Marburg virus envelope glycoprotein
#275SMC COMBINATION THERAPY FOR THE TREATMENT OF CANCER
#276Combination therapy for treatment of brain cancers
#277Treatment of heart disease by disruption of the anchoring of PP2A
#278TREATMENT OF LYSOSOMAL STORAGE DISEASE IN THE EYE THROUGH ADMINISTRATION OF AAVS EXPRESSING TPP1
#279Compositions and methods for treating motor neuron diseases
#280Prevention and/or treatment of hearing loss or impairment
#281Methods and compositions for treating cone-rod retinal dystrophy
#282Gene therapies for lysosomal disorders
#283Biomarkers and combination therapies using oncolytic virus and immunomodulation
#284Oncolytic virotherapy with helper-dependent adenoviral-based vectors expressing immunomodulatory molecules
#2853-substituted piperidine compounds for Cbl-b inhibition, and use thereof
#286Gene therapies for lysosomal disorders
#287Compositions and methods for viral delivery of neoepitopes and uses thereof
#288ADENO-ASSOCIATED VIRUS (AAV) SEROTYPE 8 SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREFOR
#289Compositions and methods for producing recombinant AAV
#290Gene therapies for lysosomal disorders
#291Gene therapies for lysosomal disorders
#292Isolated recombinant oncolytic adenoviruses, pharmaceutical compositions, and uses thereof for drugs for treatment of tumors and/or cancers
#293Oncolytic adenoviral vector and methods of use
#294Prostate neoantigens and their uses
#295Method to Curtail the Progression of Non-Muscle Invasive Bladder Cancer To Muscle-Invasive Cancer
#296Variant RNAi
#297Gene therapy strategy to restore electrical and cardiac function, and cardiac structure, in arrhythmogenic right ventricular cardiomyopathy
#298Oncolytic virus for expression of immune checkpoint modulators
#299Adenovirus comprising an albumin-binding moiety
#300Cell line for producing adenovirus and method of preparing the same